LY2922470
| Catalog Number | Pack Size | List Price* | Quantity | |
|---|---|---|---|---|
| HY-19835-1MG | 1 mg | 194,00 | Add | |
| HY-19835-5MG | 5 mg | 393,00 | Add | |
| HY-19835-1ML | 10mM/1mL | 411,00 | Add | |
| HY-19835-10MG | 10 mg | 584,00 | Add | |
| HY-19835-50MG | 50 mg | 1'534,00 | Add | |
| HY-19835-100MG | 100 mg | 2'420,00 | Add |
* CHF, excl. 8.1% VAT and shipping costs
Product Description
Best price guarantee – we offer you the lowest price in Switzerland. Please contact us for a quote if needed.
LY2922470 is a potent, selective and orally available agonist of the G protein-coupled receptor 40 (GPR40), with EC50s of 7 nM, 1 nM and 3 nM for human GPR40, mouse GPR40 and rat GPR40, respectively. LY2922470 reduces glucose levels along with significant increases in insulin and GLP-1, is potential for the treatment of type 2 diabetes mellitus (T2DM)[1].
| Category | Biochemicals |
| Supplier | MedChem Express |
| Regulatory Status | RUO |
| Research Field | Metabolic Disease, GPCR/G Protein |
| Format | Solubility: DMSO : ≥ 125 mg/mL |
| Grade | Clinical information: Phase 1 |
| Purity | 99.87% |
| Molecular Formula | C28H29NO4S |
| Molecular Weight | 475.6 |
| CAS-Number | 1423018-12-5 |
| Storage Conditions | 4°C (Powder, protect from light) |
| Tech. Data Sheet | View datasheet |
| Link To Supplier | http://www.medchemexpress.com |
| Shipping Details | Room Temperature |
| Material Safety Data Sheet | Download PDF |
